Search by Drug Name or NDC

    NDC 60505-0183-01 CARBAMAZEPINE 200 mg/1 Details

    CARBAMAZEPINE 200 mg/1

    CARBAMAZEPINE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is CARBAMAZEPINE.

    Product Information

    NDC 60505-0183
    Product ID 60505-0183_629021d1-1ccd-ed40-643e-17704ad0e848
    Associated GPIs 72600020000305
    GCN Sequence Number 004558
    GCN Sequence Number Description carbamazepine TABLET 200 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 17450
    HICL Sequence Number 001893
    HICL Sequence Number Description CARBAMAZEPINE
    Brand/Generic Generic
    Proprietary Name CARBAMAZEPINE
    Proprietary Name Suffix n/a
    Non-Proprietary Name CARBAMAZEPINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/1
    Substance Name CARBAMAZEPINE
    Labeler Name Apotex Corp.
    Pharmaceutical Class Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mo
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075948
    Listing Certified Through 2024-12-31

    Package

    NDC 60505-0183-01 (60505018301)

    NDC Package Code 60505-0183-1
    Billing NDC 60505018301
    Package 1000 TABLET in 1 BOTTLE (60505-0183-1)
    Marketing Start Date 2002-09-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.18417
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description CARBAMAZEPINE 200 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis